MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
ELEV Elevation Oncology
- 0.580
- -0.046-7.30%
Close Dec 20 16:00 ET
- 0.608
- +0.028+4.83%
Post 19:58 ET
34.29MMarket Cap-0.73P/E (TTM)
0.660High0.550Low2.50MVolume0.620Open0.626Pre Close1.49MTurnover6.50%Turnover RatioLossP/E (Static)59.12MShares5.83052wk High0.49P/B22.34MFloat Cap0.44052wk Low--Dividend TTM38.51MShs Float16.220Historical High--Div YieldTTM17.58%Amplitude0.363Historical Low0.594Avg Price1Lot Size
About Elevation Oncology Company
Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.
Company Profile
SymbolELEV
Company NameElevation Oncology
Listing DateJun 25, 2021
Issue Price16.00
Founded2019
CEOMr. Joseph J. Ferra, Jr
MarketNASDAQ
Employees29
Fiscal Year Ends12-31
Address101 Federal Street,Suite 1900,12th Floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02110
Phone1-716-371-1125
Company Executives
- Name
- Position
- Salary
- Joseph J. Ferra, Jr
- President, Chief Executive Officer and Director
- 1.24M
- Tammy Furlong
- Chief Financial Officer and Principal Accounting Officer
- --
- Valerie Malyvanh Jansen
- Chief Medical Officer
- 836.06K
- Dr. David Dornan, PhD
- Chief Scientific Officer
- 771.04K
- Steven A. Elms
- Chairman of the Board
- 113.08K
- R. Michael Carruthers
- Independent Director
- 86.48K
- Dr. Alan B. Sandler, M.D.
- Independent Director
- --
- Dr. Darcy Mootz, PhD
- Independent Director
- --
- Julie M. Cherrington, PhD
- Independent Director
- --
- Dr. Timothy P. Clackson,PhD
- Independent Director
- 84.48K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.